+1 347 708 0418
This report studies the Microbiome Therapeutics market, covering market size for segment by type (Fecal Microbiota Transplantation (FMT), Microbiome Drugs, etc.), by application (Gastrointestinal Disorders, Autoimmune Disorders, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Vedanta, Seres Therapeutics, Second Genome, Rebiotix, ActoGeniX, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Microbiome Therapeutics from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Microbiome Therapeutics market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of Microbiome Therapeutics including:
Vedanta
Seres Therapeutics
Second Genome
Rebiotix
ActoGeniX
Enterome BioScience
AvidBiotics
4D Pharma Research
Enterologics
Metabogen
Metabiomics
Ritter Pharmaceuticals
Osel
Symberix
Miomics
Symbiotix Biotherapies
MicroBiome Therapeutics
Assembly Biosciences
Synthetic Biologics
Interxon
Synlogic
Market split by Type, can be divided into:
Fecal Microbiota Transplantation (FMT)
Microbiome Drugs
Market split by Application, can be divided into:
Gastrointestinal Disorders
Autoimmune Disorders
Diabetes
Cancers
Others
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Table of Contents
Chapter 1 Microbiome Therapeutics Market Overview
1.1 Microbiome Therapeutics Definition
1.2 Global Microbiome Therapeutics Market Size Status and Outlook (2016-2030)
1.3 Global Microbiome Therapeutics Market Size Comparison by Region (2016-2030)
1.4 Global Microbiome Therapeutics Market Size Comparison by Type (2016-2030)
1.5 Global Microbiome Therapeutics Market Size Comparison by Application (2016-2030)
1.6 Global Microbiome Therapeutics Market Size Comparison by Sales Channel (2016-2030)
1.7 Microbiome Therapeutics Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 Microbiome Therapeutics Market Segment Analysis by Player
2.1 Global Microbiome Therapeutics Sales and Market Share by Player (2019-2021)
2.2 Global Microbiome Therapeutics Revenue and Market Share by Player (2019-2021)
2.3 Global Microbiome Therapeutics Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Microbiome Therapeutics Market Segment Analysis by Type
3.1 Global Microbiome Therapeutics Market by Type
3.1.1 Fecal Microbiota Transplantation (FMT)
3.1.2 Microbiome Drugs
3.2 Global Microbiome Therapeutics Sales and Market Share by Type (2016-2021)
3.3 Global Microbiome Therapeutics Revenue and Market Share by Type (2016-2021)
3.4 Global Microbiome Therapeutics Average Price by Type (2016-2021)
3.5 Leading Players of Microbiome Therapeutics by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 Microbiome Therapeutics Market Segment Analysis by Application
4.1 Global Microbiome Therapeutics Market by Application
4.1.1 Gastrointestinal Disorders
4.1.2 Autoimmune Disorders
4.1.3 Diabetes
4.1.4 Cancers
4.1.5 Others
4.2 Global Microbiome Therapeutics Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of Microbiome Therapeutics by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 Microbiome Therapeutics Market Segment Analysis by Sales Channel
5.1 Global Microbiome Therapeutics Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Microbiome Therapeutics Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of Microbiome Therapeutics by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Microbiome Therapeutics Market Segment Analysis by Region
6.1 Global Microbiome Therapeutics Market Size and CAGR by Region (2016-2030)
6.2 Global Microbiome Therapeutics Sales and Market Share by Region (2016-2021)
6.3 Global Microbiome Therapeutics Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Microbiome Therapeutics Market Share by Type
6.4.3 North America Microbiome Therapeutics Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Microbiome Therapeutics Market Share by Type
6.5.3 Europe Microbiome Therapeutics Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Microbiome Therapeutics Market Share by Type
6.6.3 Asia-Pacific Microbiome Therapeutics Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Microbiome Therapeutics Market Share by Type
6.7.3 South America Microbiome Therapeutics Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Microbiome Therapeutics Market Share by Type
6.8.3 Middle East & Africa Microbiome Therapeutics Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Microbiome Therapeutics Players
7.1 Vedanta
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Seres Therapeutics
7.3 Second Genome
7.4 Rebiotix
7.5 ActoGeniX
7.6 Enterome BioScience
7.7 AvidBiotics
7.8 4D Pharma Research
7.9 Enterologics
7.10 Metabogen
7.11 Metabiomics
7.12 Ritter Pharmaceuticals
7.13 Osel
7.14 Symberix
7.15 Miomics
7.16 Symbiotix Biotherapies
7.17 MicroBiome Therapeutics
7.18 Assembly Biosciences
7.19 Synthetic Biologics
7.20 Interxon
7.21 Synlogic
Chapter 8 Upstream and Downstream Analysis of Microbiome Therapeutics
8.1 Industrial Chain of Microbiome Therapeutics
8.2 Upstream of Microbiome Therapeutics
8.3 Downstream of Microbiome Therapeutics
Chapter 9 Development Trend of Microbiome Therapeutics (2022-2030)
9.1 Global Microbiome Therapeutics Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global Microbiome Therapeutics Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global Microbiome Therapeutics Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global Microbiome Therapeutics Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global Microbiome Therapeutics Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure Microbiome Therapeutics Example
Figure Global Microbiome Therapeutics Revenue (Million $) Status and Outlook (2016-2030)
Figure Global Microbiome Therapeutics Revenue (Million $) Comparison by Region (2016-2030)
Figure Global Microbiome Therapeutics Revenue (Million $) Comparison by Type (2016-2030)
Figure Global Microbiome Therapeutics Revenue (Million $) Comparison by Application (2016-2030)
Figure Global Microbiome Therapeutics Revenue (Million $) Comparison by Sales Channel (2016-2030)
Table Global Microbiome Therapeutics Sales by Player (2019-2021)
Table Global Microbiome Therapeutics Sales Market Share by Player (2019-2021)
Figure Global Microbiome Therapeutics Sales Market Share by Player in 2021
Table Global Microbiome Therapeutics Revenue (Million $) by Player (2019-2021)
Table Global Microbiome Therapeutics Revenue Market Share by Player (2019-2021)
Figure Global Microbiome Therapeutics Revenue Market Share by Player in 2021
Table Global Microbiome Therapeutics Average Price by Player (2019-2021)
Figure Global Microbiome Therapeutics Average Price by Player in 2021
Figure Global Microbiome Therapeutics Players Competition Situation Top 5 Players Revenue Market Share in 2019
Figure Global Microbiome Therapeutics Players Competition Trends Top 5 Players Revenue Market Share in 2021
Figure Example of Fecal Microbiota Transplantation (FMT)
Figure Global Fecal Microbiota Transplantation (FMT) Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Microbiome Drugs
Figure Global Microbiome Drugs Revenue (Million $) and Growth Rate (2016-2021)
Table Global Microbiome Therapeutics Sales by Type (2016-2021)
Table Global Microbiome Therapeutics Sales Market Share by Type (2016-2021)
Figure Global Microbiome Therapeutics Sales Market Share by Type in 2021
Table Global Microbiome Therapeutics Revenue (Million $) by Type (2016-2021)
Table Global Microbiome Therapeutics Revenue Market Share by Type (2016-2021)
Figure Global Microbiome Therapeutics Revenue Market Share by Type in 2021
Table Global Microbiome Therapeutics Average Price by Type (2016-2021)
Figure Global Microbiome Therapeutics Average Price by Type in 2021
Table Leading Players of Microbiome Therapeutics by Type in 2021
Figure Example of Gastrointestinal Disorders
Figure Global Microbiome Therapeutics for Gastrointestinal Disorders Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Autoimmune Disorders
Figure Global Microbiome Therapeutics for Autoimmune Disorders Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Diabetes
Figure Global Microbiome Therapeutics for Diabetes Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Cancers
Figure Global Microbiome Therapeutics for Cancers Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Others
Figure Global Microbiome Therapeutics for Others Revenue (Million $) and Growth Rate (2016-2021)
Table Global Microbiome Therapeutics Sales by Application (2016-2021)
Table Global Microbiome Therapeutics Sales Market Share by Application (2016-2021)
Figure Global Microbiome Therapeutics Sales Market Share by Application in 2021
Table Leading Consumers of Microbiome Therapeutics by Application in 2021
Figure Example of Direct Channel
Figure Global Microbiome Therapeutics for Direct Channel Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Distribution Channel
Figure Global Microbiome Therapeutics for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021)
Table Global Microbiome Therapeutics Revenue by Sales Channel (2016-2021)
Table Global Microbiome Therapeutics Revenue Market Share by Sales Channel (2016-2021)
Figure Global Microbiome Therapeutics Revenue Market Share by Sales Channel in 2021
Table Leading Distributors/Dealers of Microbiome Therapeutics by Sales Channel in 2021
Table Global Microbiome Therapeutics Market Size and CAGR by Region (2016-2030)
Table Global Microbiome Therapeutics Sales by Region (2016-2021)
Table Global Microbiome Therapeutics Sales Market Share by Region (2016-2021)
Figure Global Microbiome Therapeutics Sales Market Share by Region in 2021
Table Global Microbiome Therapeutics Revenue (Million $) by Region (2016-2021)
Table Global Microbiome Therapeutics Revenue Market Share by Region (2016-2021)
Figure Global Microbiome Therapeutics Revenue Market Share by Region in 2021
Table North America Microbiome Therapeutics Sales by Country (2016-2021)
Figure North America Microbiome Therapeutics Sales Market Share by Country (2016-2021)
Table North America Microbiome Therapeutics Revenue by Country (2016-2021)
Figure North America Microbiome Therapeutics Revenue Market Share by Country (2016-2021)
Figure North America Microbiome Therapeutics Market Share by Type in 2021
Figure North America Microbiome Therapeutics Market Share by Application in 2021
Figure United States Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure United States Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Canada Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Canada Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Mexico Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Mexico Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Table Europe Microbiome Therapeutics Sales by Country (2016-2021)
Figure Europe Microbiome Therapeutics Sales Market Share by Country (2016-2021)
Table Europe Microbiome Therapeutics Revenue by Country (2016-2021)
Figure Europe Microbiome Therapeutics Revenue Market Share by Country (2016-2021)
Figure Europe Microbiome Therapeutics Market Share by Type in 2021
Figure Europe Microbiome Therapeutics Market Share by Application in 2021
Figure Germany Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Germany Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure UK Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure UK Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure France Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure France Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Italy Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Italy Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Russia Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Russia Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Spain Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Spain Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Table Asia-Pacific Microbiome Therapeutics Sales by Country (2016-2021)
Figure Asia-Pacific Microbiome Therapeutics Sales Market Share by Country (2016-2021)
Table Asia-Pacific Microbiome Therapeutics Revenue by Country (2016-2021)
Figure Asia-Pacific Microbiome Therapeutics Revenue Market Share by Country (2016-2021)
Figure Asia-Pacific Microbiome Therapeutics Market Share by Type in 2021
Figure Asia-Pacific Microbiome Therapeutics Market Share by Application in 2021
Figure China Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure China Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Japan Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Japan Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Korea Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Korea Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure India Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure India Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Southeast Asia Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Australia Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Australia Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Table South America Microbiome Therapeutics Sales by Country (2016-2021)
Figure South America Microbiome Therapeutics Sales Market Share by Country (2016-2021)
Table South America Microbiome Therapeutics Revenue by Country (2016-2021)
Figure South America Microbiome Therapeutics Revenue Market Share by Country (2016-2021)
Figure South America Microbiome Therapeutics Market Share by Type in 2021
Figure South America Microbiome Therapeutics Market Share by Application in 2021
Figure Brazil Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Brazil Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Argentina Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Argentina Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Colombia Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Colombia Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Table Middle East & Africa Microbiome Therapeutics Sales by Country (2016-2021)
Figure Middle East & Africa Microbiome Therapeutics Sales Market Share by Country (2016-2021)
Table Middle East & Africa Microbiome Therapeutics Revenue by Country (2016-2021)
Figure Middle East & Africa Microbiome Therapeutics Revenue Market Share by Country (2016-2021)
Figure Middle East & Africa Microbiome Therapeutics Market Share by Type in 2021
Figure Middle East & Africa Microbiome Therapeutics Market Share by Application in 2021
Figure UAE Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure UAE Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure Saudi Arabia Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Figure South Africa Microbiome Therapeutics Sales and Growth Rate (2016-2021)
Figure South Africa Microbiome Therapeutics Revenue (Million $) and Growth Rate (2016-2021)
Table Company Snapshot of Vedanta
Table Microbiome Therapeutics Introduction of Vedanta
Table Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share of Vedanta (2019-2021)
Table Industrial Chain of Microbiome Therapeutics
Table Manufacturing Cost Structure of Microbiome Therapeutics
Table General Manufacturing Process of Microbiome Therapeutics
Table Leading Distributors/Dealers of Microbiome Therapeutics
Table Leading Consumers of Microbiome Therapeutics
Figure Global Microbiome Therapeutics Sales and Growth Rate Forecast (2022-2030)
Figure Global Microbiome Therapeutics Revenue and Growth Rate Forecast (2022-2030)
Table Global Microbiome Therapeutics Market Size and CAGR Forecast by Region (2022-2030)
Table Global Microbiome Therapeutics Market Size and CAGR Forecast by Type (2022-2030)
Table Global Microbiome Therapeutics Market Size and CAGR Forecast by Application (2022-2030)
Table Global Microbiome Therapeutics Market Size and CAGR Forecast by Sales Channel (2022-2030)
Buy
